Home » Topics » Conferences

Conferences
RSS

Tyrosine kinase inhibitors from Warner-Lambert

Sep. 27, 1996

Improved dopaminergic agents from Zambon for cardiovascular disorders

Sep. 27, 1996

Orally bioavailable LTD4 antagonists from Menarini

Sep. 27, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Novel antiemetic/gastric prokinetic agent from Dainippon

Sep. 27, 1996

New anxiolytic from SmithKline Beecham

Sep. 27, 1996

Hypocholesterolemic and hypocholesterolemic/antioxidant compounds from Pierre Fabre

Sep. 27, 1996

Immunosuppressant oligopeptide from Italfarmaco

Sep. 27, 1996

Development of COX-2 inhibitors at Searle

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...